Cargando…
Glatiramer acetate treatment effects on gene expression in monocytes of multiple sclerosis patients
BACKGROUND: Glatiramer acetate (GA) is a mixture of synthetic peptides used in the treatment of patients with relapsing-remitting multiple sclerosis (RRMS). The aim of this study was to investigate the effects of GA therapy on the gene expression of monocytes. METHODS: Monocytes were isolated from t...
Autores principales: | Thamilarasan, Madhan, Hecker, Michael, Goertsches, Robert Hermann, Paap, Brigitte Katrin, Schröder, Ina, Koczan, Dirk, Thiesen, Hans-Jürgen, Zettl, Uwe Klaus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3852967/ https://www.ncbi.nlm.nih.gov/pubmed/24134771 http://dx.doi.org/10.1186/1742-2094-10-126 |
Ejemplares similares
-
Reassessment of Blood Gene Expression Markers for the Prognosis of Relapsing-Remitting Multiple Sclerosis
por: Hecker, Michael, et al.
Publicado: (2011) -
MicroRNA Expression Changes during Interferon-Beta Treatment in the Peripheral Blood of Multiple Sclerosis Patients
por: Hecker, Michael, et al.
Publicado: (2013) -
Elevated type I interferon-like activity in a subset of multiple sclerosis patients: molecular basis and clinical relevance
por: Hundeshagen, Alexander, et al.
Publicado: (2012) -
Multiple Sclerosis: Modulation of Toll-Like Receptor (TLR) Expression by Interferon-β Includes Upregulation of TLR7 in Plasmacytoid Dendritic Cells
por: Derkow, Katja, et al.
Publicado: (2013) -
Fingolimod alters the transcriptome profile of circulating CD4+ cells in multiple sclerosis
por: Friess, Jörg, et al.
Publicado: (2017)